This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Ulotaront (SEP-363856) is a Phase III candidate with FDA Breakthrough Therapy Designation for the treatment of schizophrenia with demonstrated efficacy…
molecule
1 year ago ●
2 mins read
Velsecorat (AZD7594) is an inhaled, non-steroidal glucocorticoid receptor modulator and antedrug (soft drug) for treatment of asthma and other respiratory…
molecule
1 year ago ●
2 mins read
Vertex recently disclosed a CNS-penetrant ELOVL1 inhibitor, in which they described preclinical safety findings in rat and cyno. In this…
molecule
1 year ago ●
2 mins read
Retinol-binding protein 4 (RBP4) is the sole carrier for retinol (vitamin A). It may also play a role in diabetes…
molecule
1 year ago ●
1 min read
RP-3500 is an oral ATR kinase inhibitor and Ph. II clinical candidate for advanced solid tumors with ATRi-sensitizing mutations, alone…
molecule
1 year ago ●
1 min read
Gout is caused by the buildup of uric acid. The main treatments are drugs that increase uric acid secretion (uricosurics,…
molecule
1 year ago ●
2 mins read
Load More
